Sign in to view content

Open-Label Study Evaluating the Effects of the CCR3 Antagonist ALK4290 in Patients With Neovascular AMD Refractory to Anti-VEGF Therapy

Michael W. Stewart, MD

Video
Published 2019

Michael W. Stewart, MD

AMD Neovascular Part II Symposium

Related

Inflammatory and Infectious Diseases Symposium
Annual Meeting Talks
2020
Higher-Order Optical Coherence Tomography Fluid Burden Assessment: Analysis From the OSPREY Trial
Justis P. Ehlers, MD, FASRS
Annual Meeting Talks
2019
Evaluation of Treatment of High Risk Proliferative Diabetic Retinopathy With Intravitreal Aflibercept Injection (ELYSIAN)
Victor Hugo Gonzalez, MD
On Demand Cases, Courses, and Papers
2018

Category: AMD-Neovascular

See more